Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
eliglustat tartrate (formerly Genz-112638)
print preview
bookmark
share with colleague
General Information
Company
Sanofi
Description
Ceramide analog that inhibits glucosylceramide synthase (GCS)
Molecular Target
Glucosylceramide synthase (GCS)
Mechanism of Action
Glucosylceramide synthase (GCS) inhibitor
Latest Stage of Development
Phase III
Indication
Gaucher's disease
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy